Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
Panja S, Truica MI, Yu CY, Saggurthi V, Craige MW, Whitehead K, Tuiche MV, Al-Saadi A, Vyas R, Ganesan S, Gohel S, Coffman F, Parrott JS, Quan S, Jha S, Kim I, Schaeffer E, Kothari V, Abdulkadir SA, Mitrofanova A.
Panja S, et al. Among authors: gohel s.
Nat Commun. 2024 Jan 8;15(1):352. doi: 10.1038/s41467-024-44686-5.
Nat Commun. 2024.
PMID: 38191557
Free PMC article.